Web-based platform for managing cancer pain
Official title: A Randomized Controlled, Open Clinical Trial of a Web-based Platform for Multifactorial Intervention in Cancer Pain Management
Run by West China Hospital · NCT06663956 · Data updated 2026-11-12
This study is testing a new app that helps people with cancer pain in rural China track their symptoms and communicate better with their doctors.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | November 10, 2024 |
| Main results expected | November 10, 2026 |
| Study ends | November 10, 2026 |
| Registry record updated | April 30, 2026 |
| Trial ID | NCT06663956 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with confirmed tumors experiencing moderate to severe cancer-related pain requiring morphine-based medication.
✕Probably not a fit
Patients with other chronic pain conditions, severe cognitive impairments, or psychiatric illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to develop a patient self-reporting applet designed to assist individuals with cancer pain in rural areas of China. The applet will enable participants to report their symptoms and monitor pain levels and medication usage in real-time, facilitating better communication with primary care physicians. By integrating cancer pain management into chronic disease management, the study seeks to enhance healthcare services and improve the quality of life for patients suffering from tumor-related pain. The trial is a Phase 3 interventional study focusing on the effectiveness of this web-based platform.
Why it matters
Potential benefit: If successful, this approach could significantly improve cancer pain management and enhance the quality of life for patients in rural areas.
How similar studies have gone: Other studies have shown promise in using digital platforms for pain management, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with tumors that are confirmed by pathological findings. * Presence of tumor-related pain that is moderate or higher and requires intervention with morphine-based pain medication (++). * Have a life expectancy of more than 6 months. * Understand and sign a consent to participate in the study, or if the patient is unable to understand the study, his/her direct caregiver must have a good understanding of the study. Exclusion Criteria: * Presence of other chronic non-cancer pain/have an unresolved pain-related condition. * Moderately severe cognitive impairment/cognitive impairment. * Have schizophrenia or other psychiatric illness. * Neither the patient nor his/her direct caregiver can understand how to use the Cancer Pain Management applet. * Being pregnant.
Where it's running
-
West China Hospital, Sichuan Universit
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Xingchen Peng
- Email: pxx2014@163.com
- Phone: 18980606753
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Triple-target radiosurgery for cancer pain using pituitary and thalamic neuromodulation
This study tests whether focused brain radiosurgery to the pituitary and specific thalamic regions can reduce pain in adults with cancer that’s not controlled by opioids or other treatments.
-
Hydromorphone plus electroacupuncture and ear acupressure for refractory cancer pain
This trial tests whether adding electroacupuncture and ear acupressure to hydromorphone extended-release tablets helps relieve refractory cancer pain.
-
Tibetree topical herbal plasters for people using opioids for cancer pain
This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.
-
Transdiscal versus paravertebral splanchnic nerve neurolysis for upper abdominal cancer pain
This will test whether the transdiscal or the paravertebral splanchnic nerve neurolysis gives better pain relief for people with severe upper abdominal cancer pain that hasn't responded to medicines.
-
MRI-guided focused ultrasound mesencephalotomy for opioid-resistant head, neck, and brachial cancer pain
This study will try MRI-guided focused ultrasound to make a tiny, precise lesion in the midbrain to relieve severe, opioid-resistant head, neck, or brachial cancer pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.